Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Int J Surg Pathol ; 29(7): 747-751, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33616415

ABSTRACT

Two sporadic cases of eosinophilic solid and cystic renal cell carcinoma (ESC RCC), at our institution, are presented in this study to contribute to the growing literature on this novel renal neoplasm. The first patient was a 38-year-old female with two synchronous renal masses measuring 3.5 and 1.9 cm on preoperative imaging. The second patient was a 44-year-old female with an incidental renal mass measuring 4 cm. Both patients underwent uncomplicated radical nephrectomies. The 1.9 cm mass in the first patient was consistent with clear cell RCC. The dominant mass in the first patient and the tumor in the second patient had microscopic and macroscopic findings in keeping with ESC RCC including a tan appearance, abundant eosinophilic cytoplasm, and CK20+ and CK7- staining. Both patients had an uncomplicated course following surgery with no evidence of local recurrence or distant metastatic disease for 1 and 2 years for the first and second patient accordingly. These cases contribute to a growing body of literature regarding ESC RCC including, to our knowledge, the first reported case of synchronous ESC RCC and clear cell RCC. Further research about this novel renal neoplasm is needed.


Subject(s)
Carcinoma, Renal Cell/diagnosis , Eosinophilia/diagnosis , Kidney Neoplasms/diagnosis , Kidney/pathology , Neoplasms, Multiple Primary/diagnosis , Adult , Biomarkers, Tumor , Carcinoma, Renal Cell/pathology , Eosinophilia/pathology , Female , Humans , Incidental Findings , Kidney Neoplasms/pathology , Manitoba , Mutation , Neoplasms, Multiple Primary/pathology , Sequence Analysis, DNA
2.
Am J Vet Res ; 78(2): 207-214, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28140645

ABSTRACT

OBJECTIVE To evaluate changes in conjunctival bacteria and antimicrobial susceptibility of bacteria after cataract surgery in dogs. ANIMALS 16 client-owned dogs. PROCEDURES Samples for aerobic and anaerobic culture were obtained from the conjunctival fornices of both eyes of dogs 24 hours before (week 0) and 1, 3, and 6 weeks after cataract surgery. Topical administration of ofloxacin (every 6 hours) was initiated 12 hours before surgery and continued for 3 weeks. In vitro antimicrobial susceptibility was determined by Kirby-Bauer disk diffusion and a commercially available test for ofloxacin. RESULTS Frequency of positive culture results was significantly higher at week 6 than at weeks 0 and 1. Bacterial load was more likely to be moderate or high at weeks 3 and 6 than at weeks 0 and 1. The most frequently cultured organism was Staphylococcus pseudintermedius (21/78 [26.9%]), followed by coagulase-negative Staphylococcus spp (19/78 [24.4%]). Staphylococcus pseudintermedius was the organism most frequently cultured at weeks 0 (5/12), 1 (4/12), and 6 (8/19), whereas frequency of this organism was lowest at week 3 (1/20). In contrast, coagulase-negative Staphylococcus spp were the most frequently cultured organisms at week 3 (10/20). There was a significant increase in the proportion of organisms resistant to ofloxacin at week 3, compared with the proportion at week 0. CONCLUSIONS AND CLINICAL RELEVANCE The number of bacterial organisms increased and the population of conjunctival bacteria was altered and had a higher proportion resistant to ofloxacin during the 6 weeks after cataract surgery for dogs treated by use of this protocol.


Subject(s)
Anti-Infective Agents/therapeutic use , Cataract Extraction/veterinary , Cataract/veterinary , Dog Diseases/surgery , Ofloxacin/therapeutic use , Ophthalmic Solutions/therapeutic use , Animals , Anti-Infective Agents/pharmacology , Conjunctiva/microbiology , Dogs , Drug Resistance, Bacterial , Microbial Sensitivity Tests , Ofloxacin/administration & dosage , Ophthalmic Solutions/pharmacology , Staphylococcus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL